These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 34735953)

  • 1. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum per- and polyfluoroalkyl substance (PFAS) concentrations and predictors of exposure among pregnant African American women in the Atlanta area, Georgia.
    Chang CJ; Ryan PB; Smarr MM; Kannan K; Panuwet P; Dunlop AL; Corwin EJ; Barr DB
    Environ Res; 2021 Jul; 198():110445. PubMed ID: 33186575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of single and multiple per- and polyfluoroalkyl substance (PFAS) exposure with vitamin D biomarkers in African American women during pregnancy.
    Chang CJ; Barr DB; Zhang Q; Dunlop AL; Smarr MM; Kannan K; Panuwet P; Tangpricha V; Shi L; Liang D; Corwin EJ; Ryan PB
    Environ Res; 2021 Nov; 202():111713. PubMed ID: 34284018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher free thyroxine associated with PFAS exposure in first trimester. The Odense Child Cohort.
    Jensen RC; Glintborg D; Timmermann CAG; Nielsen F; Boye H; Madsen JB; Bilenberg N; Grandjean P; Jensen TK; Andersen MS
    Environ Res; 2022 Sep; 212(Pt D):113492. PubMed ID: 35597289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of per- and polyfluoroalkyl substances are associated with perturbations in lipid and amino acid metabolism.
    Prince N; Begum S; Mínguez-Alarcón L; Génard-Walton M; Huang M; Soeteman DI; Wheelock C; Litonjua AA; Weiss ST; Kelly RS; Lasky-Su J
    Chemosphere; 2023 May; 324():138228. PubMed ID: 36878362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-targeted metabolomics and associations with per- and polyfluoroalkyl substances (PFAS) exposure in humans: A scoping review.
    Guo P; Furnary T; Vasiliou V; Yan Q; Nyhan K; Jones DP; Johnson CH; Liew Z
    Environ Int; 2022 Apr; 162():107159. PubMed ID: 35231839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal exposure to per- and polyfluoroalkyl substances and pregnancy outcome in Austria.
    Kaiser AM; Forsthuber M; Widhalm R; Granitzer S; Weiss S; Zeisler H; Foessleitner P; Salzer H; Grasl-Kraupp B; Moshammer H; Hartmann C; Uhl M; Gundacker C
    Ecotoxicol Environ Saf; 2023 Jul; 259():115006. PubMed ID: 37182303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal exposure to perfluoroalkyl chemicals and anogenital distance in the offspring: A Faroese cohort study.
    Christensen JVR; Bangash KK; Weihe P; Grandjean P; Nielsen F; Jensen TK; Petersen MS
    Reprod Toxicol; 2021 Sep; 104():52-57. PubMed ID: 34182087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to legacy and novel perfluoroalkyl substance disturbs the metabolic homeostasis in pregnant women and fetuses: A metabolome-wide association study.
    Li Y; Lu X; Yu N; Li A; Zhuang T; Du L; Tang S; Shi W; Yu H; Song M; Wei S
    Environ Int; 2021 Nov; 156():106627. PubMed ID: 33991873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal perfluoroalkyl substances exposure and maternal sex steroid hormones across pregnancy.
    Rivera-Núñez Z; Kinkade CW; Khoury L; Brunner J; Murphy H; Wang C; Kannan K; Miller RK; O'Connor TG; Barrett ES
    Environ Res; 2023 Mar; 220():115233. PubMed ID: 36621543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood.
    Sinisalu L; Yeung LWY; Wang J; Pan Y; Dai J; Hyötyläinen T
    Metabolomics; 2021 Nov; 17(12):103. PubMed ID: 34816353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
    Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
    JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.